Porphyrin-Based Compounds for Tumor Imaging and Photodynamic Therapy
|Organization:||Roswell Park Cancer Institute, NY, US|
|I.P. Brief:||Roswell Park Cancer Institute’s (RPCI) tumor imaging technology provides a class of proprietary compounds for use in imaging brain tumors (as well as many other solid tumors).|
|Keywords:||tumor, imaging, PET, SPECT, FDG, Photodynamic, cancer, oncology|
|Primary Industry:||Health & Medical Devices|
|Specific Market:||Tumor Imaging Compounds|
Full IP Descriptions available on-site.